Multi-institutional analysis of aneuploidy and outcomes to chemoradiation and durvalumab in stage III non-small cell lung cancer.
Alessi JV, Price A, Richards AL, Ricciuti B, Wang X, Elkrief A, Pecci F, Di Federico A, Gandhi MM, Lebow ES, Santos PMG, Thor M, Rimner A, Schoenfeld AJ, Chaft JE, Johnson BE, Gomez DR, Awad MM, Shaverdian N.
Alessi JV, et al. Among authors: thor m.
J Immunother Cancer. 2023 Nov;11(11):e007618. doi: 10.1136/jitc-2023-007618.
J Immunother Cancer. 2023.
PMID: 37914383
Free PMC article.